---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-012261"
form_type: "8-K"
ticker: "CPIX"
cik: "0001087294"
company_name: "CUMBERLAND PHARMACEUTICALS INC"
filed_at: "2024-03-20T23:59:59+00:00"
generated_at: "2026-06-04T11:17:22.047646+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Cumberland Pharmaceuticals launches $5.8M at-the-market equity offering with H.C. Wainwright

## Summary
- ATM program filed March 20, 2024 for up to $5.8M of common stock through H.C. Wainwright as sales agent.
- Sales agent will receive 3.0% commission on gross proceeds from shares sold under the agreement.
- Proceeds intended for working capital, R&D expenses, capital expenditures, and general corporate purposes.
- Sales may occur at prevailing market prices; company may set minimum price or suspend offering at any time.
- Offering terminates upon sale of all shares or termination of agreement by either party on five days' notice.

## SEC filing metadata
- accession: 0001628280-24-012261
- form_type: 8-K
- ticker: CPIX
- cik: 0001087294
- company_name: CUMBERLAND PHARMACEUTICALS INC
- filed_at: 2024-03-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1087294/000162828024012261/0001628280-24-012261-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1087294/000162828024012261/cpix-20240320.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-012261
- JSON: https://secwatch.observer/filing/0001628280-24-012261.json
- Plain text: https://secwatch.observer/filing/0001628280-24-012261.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.